Adaptimmune

#BreakingNews We’ve received U.S. FDA accelerated approval for the first engineered cell therapy for the treatment of a solid tumor cancer. #CellTherapy #Biotech #Innovation #Oncology #CancerCare Press Release Link: https://lnkd.in/gp68yd6U

We’re incredibly honored to be included in the Fast Company Most Innovative Companies 2025 list! Over the last year, our team has worked tirelessly to bring to market the first new treatment option for synovial sarcoma in more than a decade. From the FDA accelerated approval to our first commercial patient treated, we’re proud of the work we’ve done and are excited for what’s to come! Read more: https://lnkd.in/e6z3hRHx #FastCompany #MostInnovativeCompany

What a night! Thank you Life Sciences Pennsylvania for honoring us with the 2024 Patient Impact Award. We’re honored to be among others in the industry who are driving meaningful change to improve patient care. And we’re committed to continuing our work to redefine how cancer is treated for the too many patients and families impacted by such a devastating diagnosis. #LifeSciencesPA #Biotech

When women in biotech come together, we break barriers, push boundaries, and drive groundbreaking science forward. Every day, the brilliant women across our teams are making discoveries that bring us one step closer to new hope for the patient communities we serve. Today, we celebrate you—the innovators, leaders, and changemakers shaping the future of biotech and cell therapy. Your contributions inspire us all, and we’re proud to stand alongside you in building a brighter, healthier world. #InternationalWomensDay #WomeninBiotech

How do you foster curiosity in your team? We’re kicking off Women’s History Month with some scientific leadership lessons from our own Jo Brewer. Thank you Dr. Brewer and the many, many women who embrace and foster curiosity, ask the tough questions, and tackle some of the most challenging areas of science and medicine! #WomensHistoryMonth #WomenInScience #CellTherapy

Today and every day, Adaptimmune is proud to support the rare disease community.   Together, we believe that it’s not rare to care – to care for each other, our communities, and to find new hope for rare cancers.    Learn more about how you can support the rare disease community https://lnkd.in/gk6hbAF. #RareDiseaseDay

This month, we celebrate Black History Month by honoring and amplifying the voices of Black leaders making meaningful contributions in oncology. This is a time to remember those who have come before us and those who have a vision for a more inclusive and supportive world, including Dr. Jane C. Wright and Dr. Kunle Odunsi. Dr. Jane C. Wright was a Black woman and oncology pioneer whose groundbreaking research revolutionized cancer treatment. One of the first to advocate for personalized medicine, she used patient tumor samples to tailor treatments, significantly advancing cancer care (Frontiers). At a time when opportunities for Black women in medicine were limited, Dr. Wright broke barriers, becoming a leading voice in oncology. In 1964, she was one of only seven specialists to co-found the American Society of Clinical Oncology, an organization that continues to shape the field today through its renowned ASCO conference (Frontiers). Her legacy as a trailblazer in medicine continues to inspire future generations. Dr. Kunle Odunsi is a nationally recognized leader in cancer immunotherapy, pioneering advancements that are transforming treatment. His groundbreaking work includes the development of antigen-specific vaccine therapy and next-generation adoptive T-cell immunotherapies, which have helped extend remission rates for women with ovarian cancer (The University of Chicago Medicine). Through his contributions, Dr. Odunsi continues to shape the future of cancer care and improve patient outcomes. Dr. Wright and Dr. Odunsi's research has paved the way for advancements that continue to shape the future of cancer treatment. Without the contributions of these brilliant scientists and countless others, innovations in biotech — like the work we do here at Adaptimmune — would not be possible. Their legacies inspire us to keep pushing boundaries in the fight against cancer. #BlackExcellence #CancerResearch #BHM #BlackHistoryMonth Frontiers: https://lnkd.in/e3KySVrN The University of Chicago Medicine: https://lnkd.in/eChSffJj

Today, we join Union for International Cancer Control (UICC) in recognizing World Cancer Day and the impact this disease has on so many lives around the world. This day aims to raise worldwide awareness, improve education, and trigger personal, collective and government action to promote health equity and a greater focus on the needs of people and communities. Today is an important reminder of why our team is here - to redefine the way cancer is treated. Adaptimmune’s fight with cancer is personal, and we are committed to continuously making advancements for the patient communities we serve. #WorldCancerDay #UnitedByUnique

Interested in what’s on the horizon for cell therapy? Don’t miss Adrian (Ad) Rawcliffe in a fireside chat at the Guggenheim Securities SMID Cap Biotech Conference  – February 6 at 3pm ET. Register now! https://lnkd.in/g3sNwAHe 

Look who’s included in Forbes' list of 6 Revolutionary Tech Developments That Defined 2024! Thank you to the community of scientists, clinicians, and advocates who helped us bring to market the first T-cell therapy for a solid tumor cancer. https://lnkd.in/eTuWT4Nq #Biotech #Innovation #CellTherapy